Comparative Toxicity of Bis-pyridinium Acetamide Derivatives in Human Cell Lines and their Acute Toxicity in Swiss Albino Mice

  • Devyani Swami Pharmacology and Toxicology Division, Defence Research and Development Establishment, Gwalior
  • Nandita Saxena Pharmacology and Toxicology Division, Defence Research and Development Establishment, Gwalior
  • Hitendra N Karade Process Technology Development Division, Defence Research and Development Establishment, Gwalior
  • Pravin Kumar Pharmacology and Toxicology Division, Defence Research and Development Establishment, Gwalior
Keywords: HNK oximes, 2-PAM, exposure route, median lethal dose, cytotoxicty

Abstract

Having established the antidotal efficacy of 2-(hydroxyimino)-N-(pyridin-3-yl)acetamide (HNK oximes) against Diisopropylphosphorofluoridate (DFP) and sarin poisoning. Toxicity of HNK series and 2-PAM oximes on Human cell lines and Swiss male mice i.e. in vitro and in vivo to reported. Toxicity of the oximes was investigated in Hela, Hep G2 and HEK 293 cell lines and compared with most commonly used 2-PAM. Median lethal doses (LD50) of the oximes (2-PAM, HNK-102, HNK-106, and HNK-111) were also determined following intramuscular, intraperitoneal, intravenous and oral routes of administration. All tested oximes showed no cytotoxic effect on all three cell lines in concentrations up to 0.05 mg/mL. At higher dose (0.5 mg/mL), HNK-102 found to be less toxic thus safer than 2-PAM and other oximes in all the three cell lines. In corroboration with in vitro finding, HNK-102 was found to be least toxic compared to other oximes via intra-peritoneal and intravenous routes of administration. Also, HNK-102 was found to be unequivocally safer compared to that of 2-PAM through i.m. and i.p. routes. For all tested oximes, toxicity following oral route, was found to be lower compared to injections, signifying that these are safer and convenient compounds for administration. These finding also suggested that HNK-102 is safer and better lead as an antidote compared to 2-PAM, against OP intoxicants.

Author Biographies

Devyani Swami, Pharmacology and Toxicology Division, Defence Research and Development Establishment, Gwalior
Ms Devyani Swami obtained her MSc (Medical biochemistry) from G.R. Medical College, Jiwaji University, Gwalior. Presently working as Senior Research Fellow in Pharmacology and Toxicology Division at Defence Research and Development Establishment. She is working on toxicity of organophosphorous compounds and screening of newly synthesised antidotes against organophosphorous compounds toxicity
Nandita Saxena, Pharmacology and Toxicology Division, Defence Research and Development Establishment, Gwalior
Dr Nandita Saxena obtained her PhD (Immunology) from Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow. She is presently working as Scientist ‘D’ in DRDE. Her main area of research includes: Abrin cytotoxicty study and screening of antidotes against Abrin toxicity
Hitendra N Karade, Process Technology Development Division, Defence Research and Development Establishment, Gwalior
Dr Hitendra N. Karade obtained his PhD (organic chemistry) from Jiwaji University, Gwalior and currently working as Scientist ‘D’ at DRDE, Gwalior since 2009. His research is mainly dedicated for the synthesis heterocyclic molecules of therapeutic applications. At present, he is working on the development of antidotes against organophosphorus poisoning.
Pravin Kumar, Pharmacology and Toxicology Division, Defence Research and Development Establishment, Gwalior
Dr Pravin Kumar obtained his MSc (Medical) Pharmacology from Smt NHLM Medical college, Gujrat University, Ahmadabad and PhD (Medical Pharmacology) from Jiwaji University, Gwalior. Currently working as Scientist ‘G’, Associate Director and Head of Pharmacology and Toxicology Division at Defence Research and Development Establishment, Gwalior. He has published in more than 60 national and international Journals and has five patents signed under him. His area of research includes medical counter measures against chemical warfare agents and evaluation of safety of compounds of defence interest. He has expertise in Inhalation toxicity studies.
Published
2016-10-07
How to Cite
Swami, D., Saxena, N., Karade, H., & Kumar, P. (2016). Comparative Toxicity of Bis-pyridinium Acetamide Derivatives in Human Cell Lines and their Acute Toxicity in Swiss Albino Mice. Defence Life Science Journal, 1(2), 149-154. https://doi.org/10.14429/dlsj.1.10733
Section
Research Article